<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32386536</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6605</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>07</Day></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Mantis-ml: Disease-Agnostic Gene Prioritization from High-Throughput Genomic Screens by Stochastic Semi-supervised Learning.</ArticleTitle><Pagination><StartPage>659</StartPage><EndPage>678</EndPage><MedlinePgn>659-678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajhg.2020.03.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9297(20)30108-7</ELocationID><Abstract><AbstractText>Access to large-scale genomics datasets has increased the utility of hypothesis-free genome-wide analyses. However, gene signals are often insufficiently powered to reach experiment-wide significance, triggering a process of laborious triaging of genomic-association-study results. We introduce mantis-ml, a multi-dimensional, multi-step machine-learning framework that allows objective assessment of the biological relevance of genes to disease studies. Mantis-ml is an automated machine-learning framework that follows a multi-model approach of stochastic semi-supervised learning to rank disease-associated genes through iterative learning sessions on random balanced datasets across the protein-coding exome. When applied to a range of human diseases, including chronic kidney disease (CKD), epilepsy, and amyotrophic lateral sclerosis (ALS), mantis-ml achieved an average area under curve (AUC) prediction performance of 0.81-0.89. Critically, to prove its value as a tool that can be used to interpret exome-wide association studies, we overlapped mantis-ml predictions with data from published cohort-level association studies. We found a statistically significant enrichment of high mantis-ml predictions among the highest-ranked genes from hypothesis-free cohort-level statistics, indicating a substantial improvement over the performance of current state-of-the-art methods and pointing to the capture of true prioritization signals for disease-associated genes. Finally, we introduce a generic mantis-ml score (GMS) trained with over 1,200 features as a generic-disease-likelihood estimator, outperforming published gene-level scores. In addition to our tool, we provide a gene prioritization atlas that includes mantis-ml's predictions across ten disease areas and empowers researchers to interactively navigate through the gene-triaging framework. Mantis-ml is an intuitive tool that supports the objective triaging of large-scale genomic discovery studies and enhances our understanding of complex genotype-phenotype associations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vitsios</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, 1 Francis Crick Avenue, CB2 0RE Cambridge, UK. Electronic address: dimitrios.vitsios@astrazeneca.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrovski</LastName><ForeName>Slav&#xe9;</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, 1 Francis Crick Avenue, CB2 0RE Cambridge, UK. Electronic address: slav.petrovski@astrazeneca.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013269" MajorTopicYN="N">Stochastic Processes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">auto-ML</Keyword><Keyword MajorTopicYN="N">gene-prioritization</Keyword><Keyword MajorTopicYN="N">genomics</Keyword><Keyword MajorTopicYN="N">keras</Keyword><Keyword MajorTopicYN="N">machine-learning</Keyword><Keyword MajorTopicYN="N">mantis-ml</Keyword><Keyword MajorTopicYN="N">positive-unlabeled learning</Keyword><Keyword MajorTopicYN="N">tensorflow</Keyword></KeywordList><CoiStatement>The authors declare no competing interests. D.V. and S.P. report personal fees from AstraZeneca, during the conduct of the study. D.V.&#x2019;s work was funded by the AstraZeneca post-doctorate program.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32386536</ArticleId><ArticleId IdType="pmc">PMC7212270</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2020.03.012</ArticleId><ArticleId IdType="pii">S0002-9297(20)30108-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zitnik M., Nguyen F., Wang B., Leskovec J., Goldenberg A., Hoffman M.M. Machine learning for integrating data in biology and medicine: Principles, practice, and opportunities. Inf. Fusion. 2019;50:71&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6242341</ArticleId><ArticleId IdType="pubmed">30467459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.D., Holzinger E.R., Li R., Pendergrass S.A., Kim D. Methods of integrating data to uncover genotype-phenotype interactions. Nat. Rev. Genet. 2015;16:85&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">25582081</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski K.J., Snyder M.P. Integrative omics for health and disease. Nat. Rev. Genet. 2018;19:299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990367</ArticleId><ArticleId IdType="pubmed">29479082</ArticleId></ArticleIdList></Reference><Reference><Citation>GTEx Consortium The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;80:648&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Vasilevsky N.A., Engelstad M., Foster E., McMurry J., Aym&#xe9; S., Baynam G., Bello S.M., Boerkoel C.F., Boycott K.M. The human phenotype ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865&#x2013;D876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210535</ArticleId><ArticleId IdType="pubmed">27899602</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C.L., Blake J.A., Kadin J.A., Richardson J.E., Bult C.J., Mouse Genome Database Group Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse. Nucleic Acids Res. 2018;46(D1):D836&#x2013;D842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753350</ArticleId><ArticleId IdType="pubmed">29092072</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M., Fagerberg L., Hallstr&#xf6;m B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson &#xc5;., Kampf C., Sj&#xf6;stedt E., Asplund A. Tissue-based map of the human proteome. Science. 2015;80:347.</Citation><ArticleIdList><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Wernersson R., Hansen R.B., Horn H., Mercer J., Slodkowicz G., Workman C.T., Rigina O., Rapacki K., St&#xe6;rfeldt H.H. A scored human protein-protein interaction network to catalyze genomic interpretation. Nat. Methods. 2017;14:61&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839635</ArticleId><ArticleId IdType="pubmed">27892958</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovski S., Wang Q., Heinzen E.L., Allen A.S., Goldstein D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9:e1003709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3749936</ArticleId><ArticleId IdType="pubmed">23990802</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynelis J., Silk M., Wang Q., Berkovic S.F., Liu L., Ascher D.B., Balding D.J., Petrovski S. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation. Genome Res. 2017;10:1715&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630035</ArticleId><ArticleId IdType="pubmed">28864458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T., O&#x2019;Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., Exome Aggregation Consortium Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Povysil G., Petrovski S., Hostyk J., Aggarwal V., Allen A.S., Goldstein D.B. Rare-variant collapsing analyses for complex traits: guidelines and applications. Nat. Rev. Genet. 2019;20:747&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pubmed">31605095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;80:1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron-Christie S., Wolock C.J., Groopman E., Petrovski S., Kamalakaran S., Povysil G., Vitsios D., Zhang M., Fleckner J., March R.E. Exome-Based Rare-Variant Analyses in CKD. J.&#xa0;Am. Soc. Nephrol. 2019;30:1109&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551770</ArticleId><ArticleId IdType="pubmed">31085678</ArticleId></ArticleIdList></Reference><Reference><Citation>Epi4K consortium. Epilepsy Phenome/Genome Project Ultra-rare genetic variation in common epilepsies:&#xa0;a case-control sequencing study. Lancet Neurol. 2017;16:135&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">28102150</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaten L., Hinton G. Visualizing Data using t-SNE. Journal of Machine Learning Research, 2008</Citation></Reference><Reference><Citation>McInnes L., Healy J., Saul N., Gro&#xdf;berger L. UMAP: Uniform Manifold Approximation and Projection. The Journal of Open Source Software. 2018;29:861.</Citation></Reference><Reference><Citation>Elkan C., Noto K. Association for Computing Machinery; 2008. Learning classifiers from only positive and unlabeled data KDD &#x2019;08: Proceedings of the 14th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; pp. 213&#x2013;220.</Citation></Reference><Reference><Citation>Mordelet F., Vert J.P. A bagging SVM to learn from positive and unlabeled examples. Pattern Recognition Letters, 2014</Citation></Reference><Reference><Citation>Kaboutari A., Bagherzadeh J., Kheradmand F. An Evaluation of Two-Step Techniques for Positive-Unlabeled Learning in Text Classification. International Journal of Computer Applications Technology and Research. 2014;3:592&#x2013;594.</Citation></Reference><Reference><Citation>Kursa M.B., Rudnicki W.R. Feature selection with the boruta package. Journal of Statistical Software, 2010</Citation></Reference><Reference><Citation>Petrovski S., Todd J.L., Durheim M.T., Wang Q., Chien J.W., Kelly F.L., Frankel C., Mebane C.M., Ren Z., Bridgers J. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2017;196:82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519963</ArticleId><ArticleId IdType="pubmed">28099038</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskarides K., Papagregoriou G., Hadjipanagi D., Petrou I., Savva I., Elia A., Athanasiou Y., Pastelli A., Kkolou M., Hadjigavriel M. COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect? BMC Nephrol. 2018;19:114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954460</ArticleId><ArticleId IdType="pubmed">29764427</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun D.A., Warejko J.K., Ashraf S., Tan W., Daga A., Schneider R. Genetic variants in the LAMA5 gene in pediatric nephrotic syndrome. Nephrology Dialysis Transplantation. 2018;34:485&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6399483</ArticleId><ArticleId IdType="pubmed">29534211</ArticleId></ArticleIdList></Reference><Reference><Citation>Prikhodina L., Lebedenkova M., Papizh S., Shatalov P. MP837LAMA5 variants in childhood steroid-resistant nephrotic syndrome: candidate gene mutations or incidental findings? Nephrology Dialysis Transplantation, 2017</Citation></Reference><Reference><Citation>Baylis C. Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. 2007</Citation></Reference><Reference><Citation>Ramanathan G., Periyasamy S., Lakkakula B.V. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease. Nephrology (Carlton) 2014;19:537&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">24824375</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand S., Chue C.D., Edwards N.C., Hodson J., Simmonds M.J., Hamilton A., Gough S.C., Harper L., Steeds R.P., Townend J.N. Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease. PLoS ONE. 2015;10:e0116160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303420</ArticleId><ArticleId IdType="pubmed">25612295</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagase S., Suzuki H., Wang Y., Kikuchi S., Hirayama A., Ueda A., Takada K., Oteki T., Obara M., Aoyagi K., Koyama A. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol. Cell. Biochem. 2003;244:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">12701818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuttke M., Wong C.S., W&#xfc;hl E., Epting D., Luo L., Hoppmann A., Doyon A., Li Y., S&#xf6;zeri B., Thurn D., CKDGen Consortium Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium. Nephrol. Dial. Transplant. 2016;31:262&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829056</ArticleId><ArticleId IdType="pubmed">26420894</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Lu D., Liu H., Williams B.O., Overbeek P.A., Lee B., Zheng L., Yang T. Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling. Hum. Mol. Genet. 2017;26:2949&#x2013;2960.</Citation><ArticleIdList><ArticleId IdType="pubmed">28486600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Yang T., Lu D.W., Zhao H., Feng Y.L., Chen H., Chen D.Q., Vaziri N.D., Zhao Y.Y. Central role of dysregulation of TGF-&#x3b2;/Smad in CKD progression and potential targets of its treatment. Biomed. Pharmacother. 2018;101:670&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">29518614</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K., Balkin D.M., Liu L., Nandez R., Wu Y., Tian X., Wang T., Nussbaum R., De Camilli P., Ishibe S. Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy. J.&#xa0;Am. Soc. Nephrol. 2017;28:1399&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407733</ArticleId><ArticleId IdType="pubmed">27895154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezu M., Suzuki N., Yamamoto M. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression. Am. J. Nephrol. 2017;45:473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">28502971</ArticleId></ArticleIdList></Reference><Reference><Citation>Noebels J.L. The Voltage-Gated Calcium Channel and Absence Epilepsy. In: Noebels J.L., Avoli M., Rogawski M.A., Olsen R.W., Delgado-Escueta A.V., editors. Jasper&#x2019;s Basic Mechanisms of the Epilepsies. National Center for Biotechnology Information; 2013.</Citation></Reference><Reference><Citation>Heyes S., Pratt W.S., Rees E., Dahimene S., Ferron L., Owen M.J., Dolphin A.C. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog. Neurobiol. 2015;134:36&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658333</ArticleId><ArticleId IdType="pubmed">26386135</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson S.M. Inhibition of transmitter release and attenuation of anti-retroviral- associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. J. Biol. Chem. 2012;287:35065&#x2013;35077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3471755</ArticleId><ArticleId IdType="pubmed">22891239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirito M., Lin Q., Deng J.M., Behringer R.R., Sawadogo M. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl. Acad. Sci. USA. 1998;95:3758&#x2013;3763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19910</ArticleId><ArticleId IdType="pubmed">9520440</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijayatunge R., Chen L.F., Cha Y.M., Zannas A.S., Frank C.L., West A.E. The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival. Mol. Cell. Neurosci. 2014;61:187&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4138546</ArticleId><ArticleId IdType="pubmed">24983519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindgren A.M., Hoyos T., Talkowski M.E., Hanscom C., Blumenthal I., Chiang C., Ernst C., Pereira S., Ordulu Z., Clericuzio C. Haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palate. Hum. Genet. 2013;132:537&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627823</ArticleId><ArticleId IdType="pubmed">23354975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez A.Y., Wang X., Xu M., Maheshwari A., Curry D., Lam S., Adesina A.M., Noebels J.L., Sun Q.Q., Cooper E.C. Ankyrin-G isoform imbalance and interneuronopathy link epilepsy and bipolar disorder. Mol. Psychiatry. 2017;22:1464&#x2013;1472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5798616</ArticleId><ArticleId IdType="pubmed">27956739</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal Z., Vandeweyer G., van der Voet M., Waryah A.M., Zahoor M.Y., Besseling J.A., Roca L.T., Vulto-van Silfhout A.T., Nijhof B., Kramer J.M. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Hum. Mol. Genet. 2013;22:1960&#x2013;1970.</Citation><ArticleIdList><ArticleId IdType="pubmed">23390136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman A., Thouta S., Mancini G.M.S., Naidu S., van Slegtenhorst M., McWalter K., Person R., Mwenifumbo J., Salvarinova R., Guella I., CAUSES Study. EPGEN Study Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy. Am. J. Hum. Genet. 2017;101:65&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501867</ArticleId><ArticleId IdType="pubmed">28669405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mademan I., Harmuth F., Giordano I., Timmann D., Magri S., Deconinck T., Claa&#xdf;en J., Jokisch D., Genc G., Di Bella D. Multisystemic SYNE1 ataxia: confirming the high frequency and extending the mutational and phenotypic spectrum. Brain. 2016;139:e46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4958896</ArticleId><ArticleId IdType="pubmed">27197992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinaga T., Nakamura K., Ishikawa M., Yamaguchi T., Takano K., Wakui K., Kosho T., Yoshida K., Fukushima Y., Sekijima Y. A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8. Hum. Genome Var. 2017;4:17052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656760</ArticleId><ArticleId IdType="pubmed">29081981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergemalm D., Forsberg K., Jonsson P.A., Graffmo K.S., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Antti H., Marklund S.L. Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis. Mol. Cell. Proteomics. 2009;8:1306&#x2013;1317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2690489</ArticleId><ArticleId IdType="pubmed">19357085</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P., Moreno J., Aso E., Povedano M., Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany N.Y.) 2017;9:823&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics. 2013;10:722&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805862</ArticleId><ArticleId IdType="pubmed">23900692</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Robinson P.N., Wang K. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat. Methods. 2015;12:841&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718403</ArticleId><ArticleId IdType="pubmed">26192085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Bardes E.E., Aronow B.J., Jegga A.G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37:W305-11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703978</ArticleId><ArticleId IdType="pubmed">19465376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Aronow B.J., Jegga A.G. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics. 2009;10:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2657789</ArticleId><ArticleId IdType="pubmed">19245720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>